VANCOUVER, British Columbia, April 27, 2017 /PRNewswire/ -- According to a new series of reports on the European neurological device market by iData Research (www.idataresearch.com), a major emerging trend is the growth of mechanical thrombectomy devices for the treatment of ischemic stroke. As a result, mechanical thrombectomy devices have become the fastest growing segment in the European neurological device market.
This market includes stent retrievers and suction thrombectomy catheters. Stent retrievers are currently used in 50% to 60% of all thrombectomy procedures in Europe. Suction thrombectomy is also used in the majority of these procedures in Europe. Rapid growth in unit sales in this market is driven by procedural growth as a result of five pivotal clinical trials over the past several years that demonstrated improved clinical outcomes after mechanical thrombectomy treatment.
There has been a strong shift in Europe towards the use of a combination of aspiration and stent retrievers but now the market is moving even farther towards aspiration-only techniques. There has been huge variability on reported success rates with aspiration-only which influences the frequency that a stent retriever is required in combination. Additional clinical trials will drive whether the devices continue to be used in conjunction or whether one category will cannibalize shares form the other.
"The average selling price (ASP) of both categories of devices is expected to remain stable over the next several years," explains Jeffrey Wong, Strategic Analyst Manager at iData Research. "However, stent retrievers drive the overall market value due to the higher ASP it commands and the need for more than one device per procedure."
There are several competitors in this market and a few others are still attempting to gather safety and efficacy data in order to bring their products to market. This pricing pressure will not have a significant impact on ASP. Thus far, Germany is the most penetrated market in Europe and is responsible for a majority of the unit sales.
Penumbra is the leading competitor in the European mechanical thrombectomy market due to the company having the only suction thrombectomy system specifically designed for the treatment of ischemic stroke. They are also currently undergoing trials to seek approval of a 3D Revascularization device which they aim to market as an addition to their aspiration device.
Medtronic is currently the second leading competitor in the European mechanical thrombectomy market, with a majority share in the stent retriever market. Additional competitors in the European mechanical thrombectomy market include Stryker, Acandis, Neuravi, NextGen Medical System and Phenox among others.
For Further Information
More on the neurological device market in Europe can be found in a series of reports published by iData Research entitled the Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices. The suite covers reports on the following markets: cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular catheters, neurovascular guidewires, neurovascular stents, neuromodulation devices, stereotactic devices, ultrasonic aspirators, neurosurgical microscopes, mechanical thrombectomy devices and transcranial magnetic simulators.
The iData report series on neurology devices covers the U.S. and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about neurology device market data, register online or email us at firstname.lastname@example.org for a Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices brochure and synopsis.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Vascular Access, Laparoscopy, Urology, Gynecology, Endoscopy, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ophthalmics, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics and more.
We have built a reputation and earned our clients' trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.
iData Research Inc.
604-266-6933 Ext. 205
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/penumbra-medtronic-lead-europe-mechanical-thrombectomy-market-fueled-by-favorable-clinical-trials-for-the-treatment-of-ischemic-stroke-300447439.html
SOURCE iData Research